down arrow

Akums Drugs

Not Rated
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE09XN01023
  • NSEID: AKUMS
  • BSEID: 544222
INR
439.00
9.25 (2.15%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.77 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
Operating Income
4,178.00
3,654.00
3,671.00
2,722.00
2,414.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
Net Sales
4,178.00
3,654.00
3,671.00
2,722.00
2,414.00
Expenditure (Ex Depriciation)
Stock Adjustments
12.00
24.00
-87.00
-30.00
-28.00
Raw Materials Consumed
2,537.00
2,249.00
2,432.00
1,721.00
1,502.00
Power & Fuel Cost
160.00
147.00
110.00
76.00
82.00
Employee Cost
646.00
590.00
507.00
420.00
438.00
Operating Expenses
102.00
112.00
104.00
81.00
66.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
55.00
54.00
51.00
23.00
25.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
434.00
76.00
568.00
139.00
95.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
Total Expenditure
4,055.00
3,360.00
3,763.00
2,485.00
2,240.00
Operating Profit (PBDIT) excl Other Income
122.00
293.00
-91.00
237.00
174.00
Other Income
34.00
90.00
22.00
21.00
27.00
Operating Profit (PBDIT)
157.00
384.00
-69.00
258.00
201.00
Interest
50.00
46.00
16.00
6.00
19.00
Profit before Depriciation and Tax
106.00
337.00
-85.00
251.00
181.00
Depreciation
125.00
112.00
94.00
69.00
66.00
Profit Before Taxation & Exceptional Items
-19.00
225.00
-180.00
181.00
114.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
-45.00
150.00
-193.00
172.00
113.00
Provision for Tax
-46.00
52.00
57.00
48.00
70.00
Profit After Tax
0.00
98.00
-251.00
123.00
43.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
638.00
557.00
832.00
770.00
836.00
Profit Available for appropriations
634.00
652.00
579.00
894.00
880.00
Appropriations
634.00
652.00
579.00
894.00
880.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
-0.28
6.63
-17.65
949.08
357.03
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 14.32% vs -0.46% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is -58.17% vs 420.52% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 9.45% vs 177.67% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is -99.19% vs 139.04% in Mar 2023

Compare Profit and Loss Results of Akums Drugs
Markets Mojo
Figures in Rs cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
4,178.00
10,334.00
-6,156.00
-59.57%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
4,178.00
10,334.00
-6,156.00
-59.57%
Expenditure (Ex Depriciation)
Stock Adjustments
12.00
-94.00
106.00
112.77%
Raw Materials Consumed
2,537.00
3,263.00
-726.00
-22.25%
Power & Fuel Cost
160.00
129.00
31.00
24.03%
Employee Cost
646.00
2,274.00
-1,628.00
-71.59%
Operating Expenses
102.00
210.00
-108.00
-51.43%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
55.00
928.00
-873.00
-94.07%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
434.00
134.00
300.00
223.88%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
4,055.00
7,798.00
-3,743.00
-48.00%
Operating Profit (PBDIT) excl Other Income
122.00
2,536.00
-2,414.00
-95.19%
Other Income
34.00
280.00
-246.00
-87.86%
Operating Profit (PBDIT)
157.00
2,817.00
-2,660.00
-94.43%
Interest
50.00
35.00
15.00
42.86%
Profit before Depriciation and Tax
106.00
2,782.00
-2,676.00
-96.19%
Depreciation
125.00
398.00
-273.00
-68.59%
Profit Before Taxation & Exceptional Items
-19.00
2,384.00
-2,403.00
-100.80%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-45.00
2,399.00
-2,444.00
-101.88%
Provision for Tax
-46.00
457.00
-503.00
-110.07%
Profit After Tax
0.00
1,926.00
-1,926.00
-100.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
638.00
8,012.00
-7,374.00
-92.04%
Profit Available for appropriations
634.00
9,925.00
-9,291.00
-93.61%
Appropriations
634.00
9,925.00
-9,291.00
-93.61%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-0.28
47.75
-48.03
-100.59%
Profit And Loss - Net Sales
Net Sales 4,178.18 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 14.32% vs -0.46% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 122.98 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -58.17% vs 420.52% in Mar 2023

Profit And Loss - Interest
Interest 50.61 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 9.45% vs 177.67% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 0.79 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -99.19% vs 139.04% in Mar 2023